The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease. ADNI researchers collect, validate and utilize data such as MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors for the disease. Data from the North American ADNI’s study participants, including Alzheimer’s disease patients, mild cognitive impairment subjects and elderly controls, are available from this site.
New data available for Aliquot Count in the LDMS Database, version 2016-10-21. The dataset...
During ADNI1, GO and 2 the Mayo ADIRL provided “preprocessed” MRI scans for the...